期刊文献+

睫毛精华类化妆品中5种前列腺素类似物的高效液相色谱法测定及质谱验证 被引量:2

Simultaneous determination of five prostaglandins in eyelash extract cosmetics by HPLC and verification by LC-MS/MS
原文传递
导出
摘要 目的:建立了睫毛精华类化妆品中5种前列腺素类似物(比马前列素、拉坦前列素、曲伏前列素、他氟前列素、他氟乙酰胺)的高效液相色谱测定方法及液相色谱-串联质谱确证分析方法。方法:样品经甲醇超声提取,采用Agilent Poroshell 120 EC-C18柱(4.6 mm×100 mm,2.7μm)分离,以乙腈-水为流动相梯度洗脱,二级阵列管检测器(DAD)在210 nm测定,外标法定量,采用液相色谱-串联质谱进行确证。结果:5种前列腺素类似物在0.1~25μg·mL^(-1)范围内线性良好,相关系数(r2)均大于0.999,方法检出浓度(LOD)为0.3~0.6μg·g^(-1),三水平加标回收率为93.2%~108.6%,相对标准偏差(RSD)为0.60%~5.5%。结论:该方法准确、快速、简便,适用于睫毛精华液化妆品中前列腺类似物的筛查。 Objective:To develop a method for the simple determination of five prostaglandins(bimatoprost,latanoprost,travoprost,tafluprost and tafluprost ethyl amide)in eyelash enhancing cosmetics using high performance liquid chromatography(HPLC)and liquid chromatography-tandem mass spectrometry(LC-MS/MS).Method:The cosmetic samples were supersonically extracted with methanol and then separated on an Agilent Poroshell 120 EC-C18 column(4.6 mm×100 mm,2.7μm)by gradient evolution with acetonitrile-water as mobile phases.The wavelength of detection was 210 nm and the external standard method was used for quantitation.The suspected samples were further verified by LC-MS/MS.Results:The five prostaglandins had a good linearity in the range of 0.1-25μg·mL^(-1)with correlation coefficients(r2)larger than 0.999.The limits of detection(LODs)were between 0.3 and 0.6μg·g^(-1).The spiked recoveries were 93.2%to 108.6%with the relative standard deviation(RSD)of 0.6%to 5.5%.Conclusion:The method is accurate,rapid and simple.It is suitable for the quality control in eyelash enhancing cosmetics.
作者 潘晨 许勇 韩晶 茹歌 彭兴盛 郑荣 PAN Chen;XU Yong;HAN Jing;RU Ge;PENG Xing-sheng;ZHENG Rong(Shanghai Institute for Food and Drug Control,National Medical Products Administration Key Laboratory for Monitoring and Evaluation of Cosmetics,Shanghai 201203,China)
出处 《药物分析杂志》 CAS CSCD 北大核心 2021年第6期994-999,共6页 Chinese Journal of Pharmaceutical Analysis
基金 上海市药品监督管理局重大资助项目(ZD-2020-03)。
关键词 前列腺素类似物 睫毛精华 化妆品 高效液相色谱法 液相色谱-串联质谱法 prostaglandins eyelash extract cosmetics HPLC LC-MS/MS
作者简介 第一作者:潘晨,Tel:18001679320,E-mail:panchensifdc@126.com;通信作者:郑荣,Tel:18001679907,E-mail:zhengrongsifdc@163.com。
  • 相关文献

参考文献4

二级参考文献46

  • 1晏晓明.关注滴眼剂的眼表毒性[J].中华眼科杂志,2005,41(5):387-389. 被引量:70
  • 2Y.H.ZOU,G.C.Y.Chiou.青光眼药物治疗的进展(英文)[J].国际眼科杂志,2005,5(3):411-422. 被引量:9
  • 3唐细兰,黄楚龙,余敏斌.青光眼药物治疗进展[J].中国药学杂志,2005,40(18):1369-1372. 被引量:11
  • 4余敏斌,李劲嵘.青光眼药物治疗的新概念[J].中华眼科杂志,2006,42(3):283-288. 被引量:52
  • 5[1]Quaranta L,Pizzolante T,Riva I,et al.24-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucoma[J].Br J Ophthalmol,2008,92(5):1227-1231.
  • 6[2]Yildirim N,Sahin A,Gultekin S.The effect of latanoprost,bimatoprost,and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma[J].J Glaucoma,2008,17(1):36-39.
  • 7[3]Ikeda Y,Mori K,Ishibashi T,et al.Effects of switching from topical beta-blockers to latanoprost on intraocular pressure in patients with normal-tension glaucoma[J].J Ocul Pharmacol Ther,2008,24(2):230-234.
  • 8[4]Enoki M,Saito J,Hara M,et al.Additional reduction in intraocular pressure achieved with latanoprost in normal-tension glaucoma patients previously treated with unoprostone[J].Jpn J Ophthalmol,2006,50 (4):334-337.
  • 9[5]Quaranta L,Miglior S,Floriani I,et al.Effects of the timololdorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucoma[J].Invest Ophthalmol Vis Sci,2008,doi:10.1167/iovs.08-1744.
  • 10[6]Rismanchian A,Eslami F,Moeini H,et al.Efficacy of the latanoprost versus timolol/dorzolamide combination therapy in patients with primary open angle glaucoma[J].Saudi Med J,2008,29(3):384-387.

共引文献24

同被引文献17

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部